Product NDC: | 0173-0569 |
Proprietary Name: | ZOFRAN |
Non Proprietary Name: | ondansetron hydrochloride |
Active Ingredient(s): | 4 mg/1 & nbsp; ondansetron hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0173-0569 |
Labeler Name: | GlaxoSmithKline LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020781 |
Marketing Category: | NDA |
Start Marketing Date: | 19990301 |
Package NDC: | 0173-0569-00 |
Package Description: | 30 TABLET, ORALLY DISINTEGRATING in 1 DOSE PACK (0173-0569-00) |
NDC Code | 0173-0569-00 |
Proprietary Name | ZOFRAN |
Package Description | 30 TABLET, ORALLY DISINTEGRATING in 1 DOSE PACK (0173-0569-00) |
Product NDC | 0173-0569 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ondansetron hydrochloride |
Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
Route Name | ORAL |
Start Marketing Date | 19990301 |
Marketing Category Name | NDA |
Labeler Name | GlaxoSmithKline LLC |
Substance Name | ONDANSETRON |
Strength Number | 4 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] |